Spot the difference: Woodford reveals top ten holdings

Revealed this morning, the top ten positions in the newly-launched fund account for 50% of his total portfolio, and are dominated by the defensive sectors which the manager has historically favoured. Pharmaceutical firm AstraZeneca, whom Woodford supported in its attempt to stave off a takeover bid from US rival Pfizer earlier this year, represents 8.3% of the £1.6bn portfolio, with peer GlaxoSmithKline accounting for 7.1%. This is in keeping with a top ten which differs little from those of his former Invesco Perpetual UK equity income funds: eight of the ten positions are also found...